|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.53 USD | -1.82% |
|
-0.40% | -29.82% |
| 16/07 | RxSight Names Aziz Mottiwala as CEO | MT |
| 14/07 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 62.61 | 67.11 | 81.78 |
| Spread/Res. | -8.23% | -14.38% | -29.74% |
| Spread/Supp. | +2.41% | +2.41% | +16.41% |
| Support | 56.11 | 56.11 | 49.36 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TARS Stock
- Charts Tarsus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
